A novel vaccine for cervical cancer: quadrivalent human papillomavirus (types 6, 11, 16 and 18) recombinant vaccine (Gardasil^®)

References

• BernardHUThe clinical importance of the nomenclature, evolution and taxonomy of human papillomavirusesJ Clin Virol200532SS1S615753006
   PubMed Web of Science ®Google Scholar
• BrandsmaJLShlyankevichMZhangLVaccination of rabbits with an adenovirus vector expressing the papillomavirus E2 protein leads to clearance of papillomas and infectionJ Virol2004781162314671093
   PubMed Web of Science ®Google Scholar
• BreitburdFKirnbauerRHubbertNLImmunization with virus-like particles form cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infectionJ Virol1995693959637745754
   PubMed Web of Science ®Google Scholar
• BurchellANWinerRLde SanjoseSChapter 6: Epidemiology and transmission dynamics of genital HPV infectionVaccine200624Suppl 3S526116950018
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Preventionrevised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adultsJAMA1993269729308093740
   PubMed Web of Science ®Google Scholar
• ChristensenNDHöpflRDiAngeloSLAssembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodiesJ Gen Virol1994752271767521393
   PubMed Web of Science ®Google Scholar
• de JongAO’NeillTKhanAYEnhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccineVaccine20022034566412297390
   PubMed Web of Science ®Google Scholar
• de VilliersEMFauquetCBrokerTRClassification of papillomavirusesVirology2004324172715183049
   PubMed Web of Science ®Google Scholar
• DennyLQuinnMSankaranarayananRChapter 8: Screening for cervical cancer in developing countriesVaccine200624Suppl 3S71716950020
   PubMed Web of Science ®Google Scholar
• Department of Health of South AfricaNational HIV and syphilis antenatal sero-prevalence survey in South Africa, 20042005Pretoria
   Google Scholar
• DeshpandeANolanJPWhitePSTNF-a promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancerJ Infect Dis20051919697615717274
   PubMed Web of Science ®Google Scholar
• FerlayJBrayFPisaniPCancer Incidence, Mortality and Prevalence WorlwideLyonIARC-CPress IARC CancerBase No. 5 version 2.0
   Google Scholar
• FrazerIPrevention of cervical cancer through papillomavirus vaccinationNature Reviews Immunol200444654
   PubMed Web of Science ®Google Scholar
• GarlandSMHernandez-AvilaMWheelerCMQuadrivalent vaccine against human papillomavirus to prevent anogenital diseasesN Engl J Med20073561991317494933
   PubMed Web of Science ®Google Scholar
• GoldieSJKohliMGrimaDProjected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccineJ Natl Cancer Inst2004966041515100338
   PubMed Web of Science ®Google Scholar
• GovanVACarraraHRSachsJAEthnic differences in allelic distribution of IFN-g in South African women but no link with cervical cancerJ Carcinogenesis200323
   Google Scholar
• GovanVAChristensenNDBerkowerCImmunisation with recombinant BCG expressing the cottontail rabbit papillomavirus (CRPV) L1 gene provides protection from CRPV challengeVaccine20062420879316343704
   PubMed Web of Science ®Google Scholar
• GovanVAConstantDHoffmanMThe allelic distribution of -308 Tumor Necrosis Factor-alpha gene polymorphism in South African women with cervical cancer and control womenBMC Cancer200562416438713
   PubMed Web of Science ®Google Scholar
• GovanVAWilliamsonALRabbits immunised with recombinant BCG expressing the cottontail rabbit papillomavirus (CRPV) L2E7E2 genes induces regression of established papillomasVirus Res200712743817451831
   PubMed Web of Science ®Google Scholar
• HarperDMFrancoELWheelerCMSustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trialLancet200636712475516631880
   PubMed Web of Science ®Google Scholar
• HildesheimAHerreroRWacholderSEffect of Human Papillomavirus 16/18 L1 virus-like particle vaccine among young women with pre-existing infectionJAMA20072987435317699008
   PubMed Web of Science ®Google Scholar
• HinesJFGhimSJChristensenNDThe expression of L1proteins of HPV-1, HPV-6, and HPV-11 display type-specific epitopes with native conformation and reactivity with neutralizing and non-neutralizing antibodiesPathobiology199462165717537506
   PubMed Web of Science ®Google Scholar
• JansenKURosolowskyMSchultzLDVaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formationVaccine1995131509148578834
   PubMed Web of Science ®Google Scholar
• KoutskyLAEpidemiology of genital human papillomavirus infectionAm J Med1997102389217656
   PubMedGoogle Scholar
• KoutskyLAAultKAWheelerCMProof of Principle Study Investigators. A controlled trial of a human papillomavirus type16 vaccineN Engl J Med200234716455112444178
   PubMed Web of Science ®Google Scholar
• La RucheGYouBMensah-AdoIHuman Papillomavirus and Human Immunodeficiency Virus Infections: Relation with cervical dysplasia-neoplasia in African WomenInt J Cancer19987648069590121
   PubMed Web of Science ®Google Scholar
• MagnussonPKEGyllenstenUCervical cancer risk: is there a genetic component?Mol Med Today200061454810740252
   PubMedGoogle Scholar
• MarkowitzLEDunneEFSaraiyaMCenters for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)MMWR Recomm Rep200756RR-212417380109
   PubMedGoogle Scholar
• MunozNBoschFXde SanjoseSInternational Agency for Research on Cancer Multicenter Cervical Cancer Study Group Epidemiologic classification of human papillomavirus types associated with cervical cancerN Engl J Med20033485182712571259
   PubMed Web of Science ®Google Scholar
• PalmerKEBenkoADoucetteSAProtection of rabbits against cutaneous papillomavirus infection using recombinant tobacco mosaic virus containing L2 capsid epitopesVaccine20062455162516725236
   PubMed Web of Science ®Google Scholar
• RobinsonW3rdManagement of cervical cancer neoplasiaCancer Treat Res200110428730211227083
   PubMedGoogle Scholar
• RodenRBYutzyWH4thFallonRMinor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopesVirology2000270254710792983
   PubMed Web of Science ®Google Scholar
• RodenRWuTCHow will HPV vaccines affect cervical cancer?Nat Rev Cancer200667536316990853
   PubMed Web of Science ®Google Scholar
• SandersGDTairaAVCost-effectiveness of a potential vaccine for human papillomavirusEmerg Infect Dis20039374812533280
   PubMed Web of Science ®Google Scholar
• SchillerJTNardelli-HaefligerDChapter 17: Second generation HPV vaccines to prevent cervical cancerVaccine2006Suppl 3S1475316950002
   PubMed Web of Science ®Google Scholar
• SitasFPacella-NormanRCarraraHThe spectrum of HIV-1 related cancers in South AfricaInt J Cancer2000884899211054682
   PubMed Web of Science ®Google Scholar
• StanczukGASibandaENPerreyCCancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL-10 productionInt J Cancer2001947929411745479
   PubMed Web of Science ®Google Scholar
• StanleyMImmune intervention in HPV infections: current progress and future developmentsExpert Rev Vaccines20032615714711323
   PubMedGoogle Scholar
• TairaAVNeukermansCPSandersGDEvaluating human papillomavirus vaccination programsEmerg Infect Dis20041019152315550200
   PubMed Web of Science ®Google Scholar
• VillaLLCostaRLPettaCAProphylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trialLancet Oncol20056271815863374
   PubMed Web of Science ®Google Scholar
• VillaLLCostaRLPettaCAHigh sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-upBr J Cancer20069514596617117182
   PubMed Web of Science ®Google Scholar
• [WHO] World Health OrganizationVaccines against human papillomavirus [online]2004 Accessed July 12, 2004. URL: http://www.who.int/vaccines/en/hpvrd.shtml/shtml
   Google Scholar
• zur HausenHPapillomaviruses causing cancer: evasion from host-cell host in early events in carcinogenesisJ Natl Cancer Inst200092690810793105
   PubMed Web of Science ®Google Scholar